References
- Lobo R A, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000; 132: 989–993
- Essah P, Nestler J E, Carmina E. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. J Endocrinol Invest 2008; 31: 35–41
- Berneis K, Rizzo M, Hersberger M, et al. Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome. Int J Clin Pract 2009; 63: 56–62
- Talbott E O, Guzick D S, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000; 20: 2414–2421
- Carmina E, Orio F, Palomba S, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006; 119: 356.e1–6
- Christian R C, Dumesic D A, Behrenbeck T, et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 2562–2568
- Carmina E, Di Fede G, Pepe I, et al. Increased lean mass in PCOS: correlation with insulin resistance and intima media thickness. Am J Med, submitted
- Dahlgren E, Janson P O, Johansson S, et al. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 1992; 71: 599–604
- Pierpoint T, McKeigue P M, Isaacs A J, Wild S H, Jacobs H S. Mortality of woman with polycystic ovary syndrome at long term follow up. J Clin Epidemiol 1998; 51: 581–586
- Wild S H, Pierpoint T, Mckeigue P M, Jacobs H S. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 2000; 52: 595–600
- Dawber T R, Meadors G F, Moore F E, Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951; 41: 279–281
- Shaw L J, Merz C N, Azziz R, et al. Post-menopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 2008; 93: 1276–1284
- Labrie F, Belanger A, Cusan L, Gomez J, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396–2402
- Koivunen R, Laatikainen T, Tomas C, et al. The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynecol Scand 1999; 78: 137–141
- Elting M W, Korsen T J, Rekers-Mombarg L T, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000; 15: 24–28